New shot JMT108 targets tough melanoma in early trial
NCT ID NCT07280832
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called JMT108 in people with advanced melanoma that cannot be removed by surgery or has spread. The goal is to check if the drug is safe and helps shrink tumors. About 188 adults who have tried other treatments without success will receive JMT108 injections in different doses.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE LOCALLY ADVANCED OR METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BeiJing Cancer Hospital EC
RECRUITINGBeijing, Beijing Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.